Open AccessBuccal cancer in a female patient with human immunodeficiency virus-2 infection
Author(s) -
Uday A Phatak,
Dinesh K Badakh
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.143353
Subject(s) - buccal administration , buccal mucosa , human immunodeficiency virus (hiv) , medicine , cancer , virus , virology , buccal swab , protease inhibitor (pharmacology) , viral load , polymerase chain reaction , immunodeficiency , immunology , biology , antiretroviral therapy , immune system , oral cavity , dentistry , microbiology and biotechnology , biochemistry , gene
This is the first-case report of isolated human immunodeficiency virus-2 (HIV-2) infection that developed squamous cell carcinoma (SCC) of the buccal mucosa. She was treated with radiotherapy 66 Gy in 30 fractions. HIV-2 infection was diagnosed with Tridot test, and quantitative estimation was done with polymerase chain reaction. Viral load is usually low in HIV-2 patients; similarly tempo of disease progression is also slow. Treatment of SCC of buccal mucosa with or without HIV infection is not different. Protease inhibitor-based anti-retroviral therapy is an appropriate treatment for HIV-2 infection